Haemonetics (HAE) Receivables (2010 - 2026)

Haemonetics' Receivables history runs 17 years deep, the most recent figure standing at $216.9 million for Q1 2026.

• In Q1 2026, Receivables rose 7.01% year-over-year to $216.9 million; the TTM figure through Mar 2026 stood at $216.9 million (up 7.01% YoY), while the FY2026 annual figure was $216.9 million, up 7.01% from the prior year.
• Receivables was $216.9 million for Q1 2026 at Haemonetics, up from $195.7 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $216.9 million in Q1 2026 to a low of $152.9 million in Q3 2022.
• Historically, Receivables has averaged $191.3 million across 5 years, with a median of $198.2 million in 2025.
• The sharpest annual moves came in 2022 and 2025: Receivables climbed 24.57% in 2022, then slipped 7.66% in 2025.
• A 5-year view of Receivables shows it stood at $187.7 million in 2022, then advanced by 12.74% to $211.6 million in 2023, then rose by 0.16% to $211.9 million in 2024, then decreased by 7.66% to $195.7 million in 2025, then climbed by 10.81% to $216.9 million in 2026.
• The last three Receivables figures came in at $216.9 million (Q1 2026), $195.7 million (Q4 2025), and $207.1 million (Q3 2025), per Business Quant data.